È cambiata la prognosi della fibrosi cistica? - Primula Multimedia
È cambiata la prognosi della fibrosi cistica? - Primula Multimedia
È cambiata la prognosi della fibrosi cistica? - Primula Multimedia
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
La fisiopatologia dell’infiammazione polmonare in corso di <strong>fibrosi</strong> <strong>cistica</strong>: implicazioni...<br />
small intestine of cystic <strong>fibrosi</strong>s patients. Pediatr Res<br />
2000; 47: 344-350.<br />
9. Becker MN, Sauer MS, Muhlebach MS, et al.<br />
Cytokine secretion by cystic <strong>fibrosi</strong>s airway epithelial cells.<br />
Am J Respir Crit Care Med 2004; 169: 645-653.<br />
10. Wagner JA, Nepomuceno IB, Messner AH, et<br />
al. A phase II, double-blind, randomized, p<strong>la</strong>cebo-controlled<br />
clinical trial of tgAAVCF using maxil<strong>la</strong>ry sinus<br />
delivery in patients with cystic <strong>fibrosi</strong>s with antrostomies.<br />
Hum Gene Ther 2002; 13: 1349-1359.<br />
11. Konstan MW, Davis PB. Pharmacological<br />
approaches for the discovery and development of new<br />
anti-inf<strong>la</strong>mmatory agents for the treatment of cystic<br />
<strong>fibrosi</strong>s. Adv Drug Deliv Rev 2002; 54: 1409-1423.<br />
12. Equi A, Balfour-Lynn IM, Bush A, et al. Long<br />
term azithromycin in children with cystic <strong>fibrosi</strong>s: a<br />
randomised, p<strong>la</strong>cebo-controlled crossover trial.<br />
Lancet 2002; 360: 978-984.<br />
13. Greally P, Hussein MJ, Cook AP, et al. Sputum<br />
tumour necrosis factor-alpha and leukotriene concentrations<br />
in cystic <strong>fibrosi</strong>s. Arch Dis Child 1993;<br />
68: 389-392.<br />
14. Bonfield TL, Panuska JR, Konstan MW, et al.<br />
Inf<strong>la</strong>mmatory cytokines in cystic <strong>fibrosi</strong>s lungs. Am J<br />
Respir Crit Care Med 1995; 152: 2111-2118.<br />
15. Widdicombe JH. Altered NaCl concentration of<br />
airway surface liquid in cystic <strong>fibrosi</strong>s. Pflugers Arch<br />
Eur J Physiol 2001; 443: S8-10.<br />
16. Voynow JA, Selby DM, Rose MC. Mucin gene<br />
expression (MUC1, MUC2, and MUC5/5AC) in<br />
nasal epithelial cells of cystic <strong>fibrosi</strong>s, allergic rhinitis,<br />
and normal individuals. Lung 1998; 176: 345-354.<br />
17. Goldman MJ, Anderson GM, Stolzenberg ED,<br />
et al. Human beta-defensin-1 is a salt-sensitive<br />
antibiotic in lung that is inactivated in cystic <strong>fibrosi</strong>s.<br />
Cell 1997; 88: 553-560.<br />
18. Kelley TJ, Drumm ML. Inducible nitric oxide synthase<br />
expression is reduced in cystic <strong>fibrosi</strong>s murine<br />
and human airway epithelial cells. J Clin Invest<br />
1998; 102: 1200-1207.<br />
19. Koehler DR, Downey GP, Sweezey NB, et al.<br />
Lung inf<strong>la</strong>mmation as a therapeutic target in cystic<br />
<strong>fibrosi</strong>s.Am J Respir Cell Mol Biol 2004; 31: 377-381.<br />
20. Greene CM, Carroll TP, Smith SG, et al. TLRinduced<br />
inf<strong>la</strong>mmation in cystic <strong>fibrosi</strong>s and non-cystic<br />
<strong>fibrosi</strong>s airway epithelial cells. J Immunol 2005; 174:<br />
1638-1646.<br />
21. Zhao Q, Lee FS. Mitogen-activated protein<br />
kinase/ERK kinase kinases 2 and 3 activate nuclear<br />
factor-kappaB through IkappaB kinase-alpha and<br />
IkappaB kinase-beta. J Biol Chem 1999; 274:<br />
8355-8358.<br />
22. Huang WC, Chen JJ, Chen CC. c-Src-dependent<br />
tyrosine phosphory<strong>la</strong>tion of IKKbeta is involved<br />
in tumor necrosis factor-alpha-induced intercellu<strong>la</strong>r<br />
adhesion molecule-1 expression. J Biol Chem 2003;<br />
278: 9944-9952.<br />
23. Kelley TJ, Elmer HL. In vivo alterations of IFN<br />
regu<strong>la</strong>tory factor-1 and PIAS1 protein levels in cystic<br />
<strong>fibrosi</strong>s epithelium. J Clin Invest 2000; 106: 403-410.<br />
24. Saadane A, Soltys J, Berger M. Role of IL-10<br />
deficiency in excessive nuclear factor-κB activation<br />
and lung inf<strong>la</strong>mmation in cystic <strong>fibrosi</strong>s transmembrane<br />
conductance regu<strong>la</strong>tor knockout mice. J<br />
Allergy Clin Immunol 2005; 115: 405-411.<br />
25. Drumm ML, Konstan MW, Schluchter MD, et<br />
al. Genetic modifiers of lung disease in cystic <strong>fibrosi</strong>s.<br />
N Engl J Med 2005; 353: 1443-1453.<br />
26. Barbato A, Turato G, Baraldo S, et al. Airway<br />
inf<strong>la</strong>mmation in childhood asthma. Am J Respir Crit<br />
Care Med 2003; 168: 798-803.<br />
27. Tabary O, Escotte S, Couetil JP, et al. Genistein<br />
inhibits constitutive and inducible NFkappaB activation<br />
and decreases IL-8 production by human cystic <strong>fibrosi</strong>s<br />
bronchial g<strong>la</strong>nd cells. Am J Pathol 1999; 155: 473-481.<br />
28. Takai D, Nagase T, Shimizu T. New therapeutic<br />
key for cystic <strong>fibrosi</strong>s: a role for lipoxins. Nat<br />
Immunol 2004; 5: 388-392.<br />
29. Chmiel JF, Berger M, Konstan MW. The role of<br />
inf<strong>la</strong>mmation in the pathophysiology of CF lung disease.<br />
Clin Rev Allergy Immunol 2002; 23: 5-27.<br />
30. Auerbach HS,Williams M, Kirkpatrick JA, et al.<br />
Alternate day prednisone reduces the morbidity and<br />
improves lung function in cystic <strong>fibrosi</strong>s. Lancet<br />
1985; 11: 686-688.<br />
31. Eigen H, Rosenstein BJ, FitzSimmons S,<br />
Schidlow DV. A multicenter study of alternate-day<br />
prednisolone therapy in patients with cystic <strong>fibrosi</strong>s.<br />
Cystic Fibrosis Foundation Prednisone Trial Group. J<br />
Pediatr 1995; 126: 515-523.<br />
BIBLIOGRAFIA<br />
23